There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.

The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.

While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.

What is the Quad-demic?

Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.

While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.

1. Influenza (Flu)

Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.

2. Covid-19

Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.

3. RSV

RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.

4. Norovirus

Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.

Is There a Challenge In Diagnosis Due to Overlapping Symptoms?

The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.

Also Read: Is US Preparing For A Quad- demic 2025?

Effective Prevention Strategies That Work

The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:

Vaccination

• Flu vaccine: Annual flu shots reduce the severity of infection, allergic flare ups and hospitalizations.
• COVID-19 vaccine: Though COVID-19 cases have declined, vaccination remains critical in preventing severe outcomes.
• RSV vaccine: Available for those aged 60 years and older, especially those with underlying conditions.
• Norovirus vaccine: No vaccine is yet available, but mRNA vaccine research is in progress.

Hygiene and Sanitation

• Washing hands frequently with soap and water for at least 20 seconds, especially after public exposure.
• Disinfect frequently touched surfaces regularly, use sanitiser when outside.
• Avoid close contact with infected people and wear masks.

Do You Need To Wear A Mask All The Time?

While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.

If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.

As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.

With the launch of generic versions of Ozempic, Wegovy, and Mounjaro, the demand for these weight loss and diabetes medications is skyrocketing in India. Amid the rising demand, there is also a surge of counterfeit jabs—often sold through unregulated online vendors—that can endanger lives.

According to a Reuters report, Indian drug regulators have seized more than 260 suspected counterfeit pens of Eli Lilly's popular obesity and diabetes drug Mounjaro, worth Rs 7 million, ‌from the northern state of Haryana.

The suspected fake pens were recovered from a vehicle on the outskirts of New Delhi, and were kept under improper temperature conditions and appeared in different font sizes compared with the original product, which ⁠raised suspicion of being counterfeit.

The Haryana Food and Drug Control Administration has also arrested two people accused of making and selling the drugs. The primary accused did not have a pharmaceutical license and made the products at a private property, Drug Control Officer Amandeep Chauhan told Reuters. They had ordered peptides used in the drugs and other raw materials from vendors on the Chinese e-commerce platform Alibaba.

The arrested duo also sold the pens on the online marketplace IndiaMART at a 27 per cent discount to the original drug's price, ⁠Chauhan said.

While samples have been sent to government-run laboratories for confirmation, Eli Lilly and Company (India) spokesperson issued a statement welcoming the action against illicit medicines.

Noting that it "takes patient safety extremely seriously", the company stated that it's "actively supporting the investigation and will continue to work with regulatory and law enforcement authorities worldwide to protect patients from the risks of counterfeit products".

Also read: Lehengas, Diets & Now Mounjaro: The New Must-Have For Indian Brides?

Can Fake Ozempic/Mounjaro Pens Turn Dangerous?

The short answer: extremely. The risks go far beyond inefficacy. Some fake jabs contain:

• Insulin – Can dangerously drop blood sugar, leading to seizures or coma.
• Toxic substances – Seized products have been found to contain mercury, cement, and rat poison.
• Bacteria – Due to non-sterile production environments, leading to infections.
• Wrong or mixed medications – Including none of the intended drug at all.

Read More: Can Weight Loss Jabs Surge Divorce Rates? What Experts Are Saying

How To Identify Counterfeit Ozempic/ Mounjaro Pens?

Counterfeit products may have

• spelling errors,
• instruction leaflets not in English,
• unsealed packaging,
• changes in the size, shape, or appearance of medicine

These are indicators that the medicine has not been produced by the original manufacturer or is being illegally sold in the wrong market.

Further, counterfeit drugs are often sold on social media platforms like Instagram, TikTok, or salon backrooms.

Also read: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype

Another major lure of counterfeit Ozempic/Mounjaro is the price tag—black-market versions are often heavily discounted. But remember: this comes at the cost of your health, safety, and potentially, your life.

If you’re unsure about a product, consult your pharmacist or primary care provider. Always ensure that any medication you take has been prescribed by a qualified healthcare provider and obtained from a licensed source.

As Bangladesh grapples with a surge in highly infectious measles cases, neighboring Indian states Meghalaya and Tripura are strengthening preventive measures by ramping up vaccination drives and intensifying surveillance, particularly in border districts, to curb any potential spillover and contain the spread of the disease.

As per media reports, Bangladesh is reporting more than 1,100 suspected infections in a single day. The vaccine-preventable measles has also claimed the lives of 98 children in the country’s one of the worst outbreaks.

Measles: Response In Meghalaya

To strengthen early detection and response in Indo-Bangla border areas, the Meghalaya government conducted an orientation-cum-preparedness meeting last week at the Amlarem Sub-Divisional Office with district administration and health department officials, the Border Security Force, community leaders, and grassroots workers, including ASHAs and Anganwadi workers.

Dr A Khonglah, sub-divisional medical and health officer, Amlarem, informed of a few suspected cases in the state, The Times Of India reported. Khonglah noted there was “no cause for panic”, but stressed that early reporting was critical for timely testing and treatment.

In a notification issued on Monday, Meghalaya’s state health department called for stepping up surveillance in East Khasi Hills District.

“Immediate corrective measures are required in response to ongoing measles outbreaks in Bangladesh and the heightened risk in border districts and blocks. It is imperative to strengthen surveillance, early detection, reporting, and response mechanisms across all sectors in East Khasi Hills District,” the notification said.

The state health department directives include:

• All fever with rash cases (suspected measles) in any age group should be reported immediately to the nearest health facility/ANM/medical officer.
• Ensure close coordination with the health department and World Health Organization (WHO) for timely investigation and response.
• Any child suspected of measles should be strictly restricted from attending school/AWC until complete recovery.
• The measles-suspected child should remain isolated at home with minimal contact to prevent further transmission.
• Sensitize teachers and Anganwadi Workers to identify symptoms of fever with rash.

Tripura: Closely Monitoring Measles Trends

Similarly, Health officials in Tripura are also assessing the prevailing measles and rubella situation, with a focus on vaccination coverage and containment measures.

The officials in a review meeting focused on evaluating infection trends, immunization progress, and the effectiveness of ongoing containment strategies, Northeast Today reported.

Mission Director of the National Health Mission (NHM), Saju Vaheed A on Sunday visited Unakoti district to assess the prevailing measles and rubella situation, with a focus on vaccination coverage and containment measures.

The director reviewed data on vaccination coverage and stressed the need for close monitoring of vulnerable areas.

Also read: Measles Again On The Rise Globally: Is India At Risk?

Measles: Sporadic Outbreaks In India

Since the beginning of the year, India is seeing sporadic outbreaks of measles. Madhya Pradesh's Gwalior reported three outbreaks, and Morena six.

Over January and February 2026, 41 children were diagnosed with measles in Tikari village in Madhya Pradesh.

However, swift action by health authorities with proactive frontline engagement and data-driven rapid response prevented an escalation into large measles outbreaks. These sporadic outbreaks also highlighted the critical importance of measles-rubella (MR) vaccination in protecting children and communities.

Measles in Bangladesh

As per official data, till April 19, Bangladesh recorded 3,443 confirmed measles cases and more than 23,600 suspected infections.

While over 12,000 patients have recovered, the outbreak has resulted in at least 36 confirmed deaths and 181 deaths among suspected cases, MNTV reported.

In response, Bangladesh has vaccinated more than 1.9 million children against measles and rubella in an emergency nationwide campaign.

Health Minister Sardar Md Sakhawat Husain said the situation has begun to stabilize due to early intervention, adding that vaccine supplies remain sufficient to sustain the campaign through June.

What Is Measles?

Measles is a highly contagious virus that spreads through direct contact or through the air when an infected person coughs or sneezes. It is a vaccine-preventable disease that can cause devastating complications, including blindness, pneumonia, encephalitis, and long-term immune dysfunction.

Symptoms typically appear seven to 14 days after exposure and may include:

• high fever,
• cough,
• runny nose,
• red eyes,
• rashes across the body.

To safeguard against measles, individuals should ensure timely vaccination, especially for children.

Maintaining good hygiene, such as frequent handwashing and covering the mouth while coughing or sneezing, helps reduce transmission.

Avoiding close contact with infected individuals and ensuring proper nutrition to boost immunity are also important.

Public awareness and community health programs play a crucial role in prevention.

Weight loss drugs appeal to many for their convenience, but according to some experts, there are a number of noteworthy side effects. From rapid weight gain to sagging skin, several side effects of weight loss drugs have been identified through studies. Now, new research has found that weight loss drugs can cause more muscle loss than clinical expectations. The results, presented at the American College of Physicians Internal Medicine (ACP-IM) meeting in San Francisco, add to existing evidence on the possible adverse effects of GLP-1.

Why does muscle loss occur during weight loss?

When a person loses a considerable amount of weight, they also lose bone mass, muscle mass, and some connective tissue. Experts at the University of North Carolina at Chapel Hill found that no studies directly associate muscle loss with a decline in physical function or strength. However, this clinical gap underscores the need to assess strength and mobility alongside weight loss in patients receiving this therapy. The systematic review identified 36 randomised clinical trials that measured changes in muscle mass and fat among adults using incretin-based obesity medications such as tirzepatide, dulaglutide, or semaglutide.

Each study measured body composition using MRI, CT scans, and bioelectrical impedance analysis. Most of them used DEXA along with other methods to obtain information about lean muscle mass, bone mineral density, and the distribution of body fat. The average age of participants ranged from 20 to 63.7 years. Only four studies included participants aged 60 years and above. None of the studies focused on adults aged 65 years or older.

Average muscle loss on weight loss drugs

Researchers noted a concerning trend: patients’ estimated muscle loss exceeded the 25 per cent threshold. Clinicians had expected a 25 per cent reduction, but not more than that. Experts also found that 68 per cent of people who used the drugs exceeded the 25 per cent benchmark, compared to 50 per cent of those who relied on placebos and lifestyle interventions. None of the studies measured whether the loss of muscle mass was correlated with function or strength loss.

Muscle mass diminishes with age

Despite being a concerning side effect of weight loss drugs, muscle mass is likely to diminish anyway with age. Additionally, the loss is more significant in older adults. Therefore, doctors advise caution when prescribing these drugs to individuals who are more prone to losing muscle function at an advanced age. Ideally, doctors should recommend exercise or physical therapy to patients taking weight loss medications.

The final word

According to experts, weight loss drugs do have a positive side — and that extends beyond obesity treatment. These drugs are also beneficial for diabetes and help reduce the risk of cardiovascular disease. However, it is important to support treatment with the right kind of diet and a proper exercise regimen. Solely depending on the medication can lead to weight gain once it is discontinued. Therefore, for healthy weight loss, it is best to rely on sustainable methods for long-lasting results.